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The growing importance of triarylarsines as ligands for transition metal catalysis has sparked recent 
interest in new synthetic routes to tertiary arsines that avoid hazardous arsenous chloride reagents. 
However, safer methods for the synthesis of lesser explored arsine heterocycles, especially those con-
taining As−C(sp3) bonds, remain lacking. We demonstrate for the first time that bench stable, less haz-
ardous, arylarsine(III) oxides are effective substitutes for their corresponding chlorides in the one-pot 
construction of cyclic tertiary organoarsines from di-Grignard reagents. Several known and novel het-
erocycles have been prepared in reasonable yields, accommodating variations in both the diorgano-
magnesium reagent and electrophile, making this a modular approach to cyclic arsine assembly. 
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Introduction 
Organoarsines have found application in coordination chemistry [1], materials science [2] and recently 
in chemotherapy as potential drug delivery and anti-cancer agents [3]. Triaryl arsines in particular are 
now well established as valuable ligands for transition metal catalysis, demonstrating superiority to 
analogous phosphines in many cases [4]. Although tertiary organoarsines are traditionally prepared via 
the combination of arsenic chlorides (or other halides) with organometallic reagents or nucleophilic 
arenes, a major drawback to this approach is the inherent toxicity associated with the As−Cl bond [5]. 
It is well known that arsenic compounds (or metabolites thereof) generally exhibit toxicity [6], howev-
er, most arsenous chlorides are additionally characterized by alarming acute effects based on their rapid 
in vivo covalent binding to thiol-containing enzymes and proteins [7]. These hazards are exacerbated 
by the often semi-volatility of arsenous(III) chlorides, which have historically been exploited as blister-
ing and vomiting agents in chemical warfare (e.g., Lewisite, Ph2AsCl, PhAsCl2 and Adamsite) [5]. As 
such, tertiary organoarsine syntheses that avoid this reagent class have received some interest [8], par-




In our own search for alternate methods of As−C bond formation, we turned our attention to seminal 
work by Blicke with arylarsine(III) oxides 1 (Scheme 1) [10]. In contrast to the noxious arsenous chlo-
rides, oxides 1 are generally bench-stable, non-hygroscopic solids that can be safely handled in the la-
boratory and are resistant to atmospheric oxidation [11]. These compounds (arsenous acid anhydrides) 
were shown to react with aryl Grignard reagents at ambient temperature to yield dimers 2 after addition 
of the carbanion (Scheme 1a) [10a]. Attempts to achieve a second Grignard addition were carried out 
with phenylarsine oxide 3 at elevated temperature (Scheme 1b) [10a]. In the two examples reported 
(both shown), the product ratio was highly dependent on the concentration of the Grignard regent: a 
large excess (8 equiv) was required to favour the second addition, enabling triphenylarsine to be ob-
tained in near quantitative yield.  
 
 
Scheme 1. Previous organoarsine syntheses using arylarsine oxides as electrophiles [10a]. 
Although anhydrous arylarsine oxides are often depicted as containing a π-bond (As=O), spectroscopic 
experiments have shown their existence in solid state and solution as well-defined oligomers: 
(ArAsO)x [12]. Thus, the formation of a tertiary organoarsine from 1 (or 3) likely involves the sequen-
tial cleavage of two As−O σ-bonds. In this way, arsine oxides could be considered as direct synthetic 
equivalents of arsenous chlorides.  
 
Encouraged by these findings, we became interested in investigating arsine oxides as safer substitutes 
for arsenous chlorides in the preparation of (semi)saturated arsine heterocycles 7 from di-Grignard re-
agents (Scheme 2). Analogous cyclic phosphines and their derived dimers have proven highly effective 
in ligand-assisted catalysis and asymmetric variants [13], and thus safer and wider access to molecular 
class 7 was of interest to expand the repertoire of useful arsine ligands beyond the standard triaryl spe-
cies. 
 
Scheme 2. Proposed synthesis of cyclic arsines from arylarsine oxides and di-Grignard reagents.  
Based on Blicke’s results (Scheme 1b) [10a], we proposed that di-Grignard reagents 6 would be ideal 
nucleophiles to react with oxides 1, given that the second (and evidently most challenging) As−C bond 
forming event could occur in an intramolecular mode (Scheme 2b). An additional advantage offered by 
this approach over stepwise processes was the ability to form the desired heterocycles in a single-pot, 




Results and Discussion 
The commercially available phenylarsine oxide 3 was selected as a model electrophile to begin our in-
vestigations. Although 3 is an oligomeric material, it dissolves readily in standard organic solvents (x = 
4 in benzene, CCl4 and camphor) [12a]. Arsenous chlorides have been used as electrophiles in previous 
syntheses of cyclic arsines from di-Grignard reagents (Scheme 2a) [14], therefore, by selecting known 
arsacycles 10 and 11 as initial targets for reaction optimization, a direct comparison could be made be-
tween the performance of (PhAsO)x and its corresponding dichloride (Table 1). Previous results from 
the literature using PhAsCl2 are therefore included (entries 1−6) [15−19]. 
 
Our opening experiment was performed using an equimolar quantity of di-Grignard reagent 8 with a 
20 h reaction time (entry 7). Following aqueous work-up, the desired arsolane 10 was isolated in 12% 
yield after elution through silica gel with hexanes. The remaining material consisted of a complex mix-
ture of unidentified polar components. Encouraged by our immediate success in the formation of 10, 
we proceeded to examine the effect of temperature variations: mixing the reactants at −78 °C gave a 
similar yield (entry 8), while heating the reaction at reflux was detrimental (entry 9), possibly due to 
polymerization of the arsine oxide [12b]. An extension of the reaction time to 70 h did not result in an 
improvement (entry 10), establishing that the low yields were not merely a result of a slow Grignard 
addition. 
 













1 [15] 1 1.0 PhAsCl2 rt−reflux
b 10 18 
2 [16] 1 1.1 PhAsCl2 10−rt 10 28 
3 [17] 1 3.2 PhAsCl2 10−rt 10 66 
4 [18] 2 1.3 PhAsCl2 rt−reflux
b 11 32 
5 [19] 2 1.4 PhAsCl2 0−rt
b 11 31 
6 [17] 2 3.2 PhAsCl2 10−rt 11 53 
7 1 1.0 (PhAsO)x 0−rt 10 12 
8 1 1.0 (PhAsO)x −78−rt 10 13 
9 1 1.0 (PhAsO)x −78−reflux 10 4 
10 1 1.0 (PhAsO)x −78−rt
c 10 10 
11 1 3.0 (PhAsO)x −78−rt 10 39
d 
12 1 5.0 (PhAsO)x −78−rt 10 42 
13 2 5.0 (PhAsO)x −78−rt 11 9 
14 2 5.0 (PhAsO)x 0−rt 11 36 
a Isolated yield based on electrophile. b Et2O used as solvent. c Reaction time was 70 h. d Yield determined by 1H NMR 
with DMSO as internal standard. 
Comparison of previous literature yields using PhAsCl2 reveals a significant advantage from employ-
ing an excess of the di-Grignard reagent (entries 3 and 6) [17]. This also proved to be the case in our 
experiments when the equivalents of 8, relative to (PhAsO)x, were increased 3- and 5-fold (entries 11 
and 12). From the latter reaction (entry 12), 10 was isolated in an acceptable 42% yield. Translation to 
the six-membered homologue with an excess of di-Grignard reagent 9 occurred smoothly when the ad-





Although it is evident that the previously optimized yields of 10 and 11 from the dichloride electro-
phile are higher than obtained here with (PhAsO)x (entry 3 versus 12; entry 6 versus 14), we believe 
that the benefits of avoiding hazardous PhAsCl2 outweighs these current discrepancies. Importantly, 
the current reactions are also amenable to larger-scale preparations. The arsine oxide can be weighed in 
the air with no special precautions. As an example, we have prepared 0.8 g of 10 from the reaction be-
tween 1.5 g of 3 and the di-Grignard reagent 8 (42% yield, entry 12).  
 
With phenylarsine oxide established as a viable synthon to cyclic arsines, we explored the synthesis of 
additional heterocycles using carbocylic-fused di-Grignard reagents (Table 2). Phenyl- and naphthyl-
fused bis-nucleophiles performed adequately in the cyclization, giving five-membered arsacycles 12 
and 13 in 44% and 41% yields respectively (entries 1 and 2). These results compare well with that ob-
tained for the non-aromatic analogue 10 (Table 1, entry 12). The standard flash chromatographic puri-
fication with hexanes was carried out to isolate the analogous six-membered arsine (deoxo)-14, (entry 
3), however the product was found to be contaminated with non-volatile hydrocarbons derived from 
Grignard hydrolysis and Wurtz-coupling processes. Thus, subsequent treatment with H2O2 [15] was 
performed to isolate the more polar oxide derivative 14 in an overall 26% yield. It should be noted that 
desymmetrized heterocycles 12−14 have been obtained as racemic mixtures due to the newly installed 
arsenic stereocentre. Additionally, both trans- and cis-cyclohexene-fused di-Grignard reagents reacted 
productively under the standard conditions (entries 4 and 5). The racemic trans product 15, which ex-
hibits solely backbone chirality, was isolated in 36% yield, while its cis isomer 16, bearing an addition-
al stereocentre at arsenic, was obtained after silica gel chromatography in 41% yield as a 1:1 mixture 
of the two meso compounds.  
 























(dr = 1:1) 
a See the experimental section for Grignard formation conditions. b Isolated yield based on 3. c Racemic mixture. d Reac-




Although the yields obtained for known compounds 12 and (deoxo)-14 are modest (Table 2, entries 1 
and 3), they are both superior to the previous three-step procedures (25% and 17% yields respectively) 
[20, 21], which involve Friedel-Crafts cyclization and again use hazardous PhAsCl2 as starting materi-
al. Furthermore, we have fully characterized these compounds for the first time. 
 
Importantly, this metholodogy can also be applied to arylarsine oxides of electronic and steric variabil-
ity (Scheme 3). Utilizing di-Grignard reagent 8 under the established conditions, novel arsolanes 
17−19, bearing 4-bromophenyl, 4-methoxyphenyl and 1-naphthyl substituents, were readily obtained 
in comparable yields (34−45%) to their phenyl analogue. The marginally lower yield of 18 was pre-
sumably a result of the electron-donating methoxy group, decreasing the reactivity of the electrophile. 
 
 
Scheme 3. Preparation of novel arsolanes 17−19 from various arylarsine oxides. 
As a first step to understanding why excess Grignard reagent is required for satisfactory double As−C 
bond formation, we carried out a control experiment to determine whether the cyclic arsine(III) prod-
ucts were sufficiently nucleophilic to react in situ with their oxide precursors (eq 1) [22]. Accordingly, 
exemplary substrate 11 was treated with 3 under the standard conditions of heterocycle formation. 
NMR spectroscopic analysis of the resultant mixture showed no reaction had occurred. This result 
clearly shows that the general requirement for excess Grignard reagent is not a consequence of a com-
peting reaction between the formed heterocycle and the remaining (ArAsO)x. Given that we have also 
shown that longer reaction times do not increase the yield of the di-Grignard cyclization (Table 1, entry 
10), we currently speculate that a higher concentration of the Grignard reagent activates the electro-
phile by Lewis acid coordination and/or affects the degree of (ArAsO)x association in solution. Further 
studies are required to validate these arguments.  
 
In the course of this work, we found all arylarsine(III) heterocycles to be relatively stable compounds; 
no oxidation or decomposition was observed during work-up and chromatographic purification, with-
out special precautions to exclude atmospheric oxygen and moisture. Selected compounds were none-
theless readily converted to their As(V) analogues by oxidation with H2O2 [15] (Scheme 4). No 
As−C(sp3) bond cleavage was detected in these reactions, as has been observed for some acyclic 






a Previously reported in 96% yield but was not fully characterized [15]. 
Scheme 4. Oxidation of selected cyclic arsines. 
 
Conclusion 
In conclusion, we have demonstrated that arylarsine oxides can be utilized as synthetic equivalents to 
their dichloride counterparts in combination with di-Grignard reagents, allowing the preparation of cy-
clic tertiary organoarsines in a significantly less hazardous manner than previously possible. Extension 
to carbocyclic-fused di-Grignard reagents has enabled access to several novel arsacycles, including 
those with backbone and arsenic chirality, maintaining acceptable yields throughout. Modular electron-
ic and steric alteration of the peripheral aryl substituent has also been shown to be possible. Conven-
iently, these arylarsine heterocycles are stable to air and moisture, but can be readily oxidized to their 
As(V) analogues, which offer potential opportunities for functionalization via α-lithiation chemistry 
[23], including oxidative dimerization [24] to novel bisarsines. Further studies in our laboratory will 
include the examination of solvent effects and/or Lewis acid additives on the cyclization efficiency, the 
resolution of chiral racemates 12−15 and potential applications of the cyclic arsines and derived dimers 
in transition metal catalysis. 
 
Experimental 
General Information: All reactions were carried out under an atmosphere of N2 in oven-dried glass-
ware with magnetic stirring. Thin layer chromatography (TLC) was performed on aluminum-backed 
0.20 mm silica gel plates. Visualization was accomplished with UV light or an aqueous ceric ammoni-
um molybdate solution. Flash chromatography was performed under positive air pressure using Silica 
Gel 60 of 230−400 mesh (40−63 m). Infrared (IR) spectra were obtained with neat samples on a Shi-
madzu IRAffinity-1 FTIR Spectrometer. Proton and carbon magnetic resonance spectra (1H NMR and 
13C NMR) were recorded on a Varian Mercury 300 MHz spectrometer, a Varian Inova 500 MHz spec-
trometer or a Varian VNMRS PS54 500 MHz spectrometer. All spectra were acquired in CDCl3 and are 
reported relative to tetramethylsilane (1H:  = 0.00 ppm) and solvent resonance (13C:  = 77.0 ppm). 1H 
NMR data are reported as follows: chemical shift, multiplicity (d = doublet, t = triplet, m = multiplet), 
coupling constant (Hz), integration and assignment. Low resolution mass spectrometry (MS) was per-
formed on a Shimadzu LC-2010 Electrospray Ionization (ES) Mass Spectrometer or on a Shimadzu 
QP-5050 Electron Impact (EI) Spectrometer. High resolution mass spectrometry (HRMS) was per-
formed on a Waters Quadrupole-Time of Flight (QTOF) Xevo ES Spectrometer with Leucine-
Enkephalin as an internal standard or on a Fison/VG Autospec-TOF EI Spectrometer at 70 eV with a 
source temperature of 250 °C. 
 
Nitrogen (N2) was dried by passage through self-indicating silica gel (blue, 2−4 mm bead size). Known 
halogenated Grignard precursors unavailable commercially were prepared according to literature 
methods cited within. Grignard reagents were prepared from Mg turnings that were freshly washed 




vacuum. Phenylarsine oxide (PhAsO)x and anhydrous tetrahydrofuran were purchased and used as re-
ceived. The known 4-bromo-[25], 4-methoxy-[10b] and 1-napthylarsine oxides [10b] were prepared in 
two steps from the corresponding anilines via diazonium salt activation in the presence of arsenic tri-
oxide [26], then reduction of the arsonic acids with an iodine/ascorbic acid system [12d]. All other rea-
gents and solvents were purchased reagent grade and used without further purification. 
 
Synthesis of 1-Phenylarsolane (10) 
A suspension of Mg (2.215 g, 91.12 mmol) and 1,4-dibromobutane (9.838 g, 45.56 mmol) in THF (70 
mL) was stirred at rt for 1 h. The resulting dark grey solution was added dropwise to a solution of 
(PhAsO)x (1.532 g, 9.11 mmol) in THF (70 mL) at −78 °C and the mixture was allowed to warm to rt 
and stirred for 20 h. Water (50 mL) was slowly added and the mixture was extracted with CH2Cl2 
(3×50 mL). The combined extracts were dried (MgSO4), concentrated and subjected to column chro-
matography (hexanes) giving 10 [17] (803 mg, 42%) as a colorless oil. This compound has been fully 
characterized previously [17]. NMR data for the sample prepared herein was consistent with the pub-
lished data, with the exception that the quaternary aromatic carbon [As−C(sp2)] was significantly fur-
ther downfield than previously reported (lit: δ = 132.5 [17], our sample: δ = 143.3). 1H NMR (CDCl3, 
500 MHz): δ 1.76-1.98 (m, 8H), 7.22-7.30 (m, 3H), 7.40-7.44 (m, 2H); 13C NMR (CDCl3, 125 MHz): 
δ 27.4, 30.4, 127.3, 128.3, 131.5, 143.3. 
 
Synthesis of 1-Phenylarsinane (11) 
A suspension of 1,5-dibromopentane (684 mg, 2.97 mmol) and Mg (145 mg, 5.97 mmol) in THF (6.3 
mL) was stirred at rt for 1.5 h. The mixture, containing a small amount of unreacted Mg, was cooled to 
0 °C and a solution of (PhAsO)x (100 mg, 0.595 mmol) in THF (4.2 mL) was added dropwise. The 
mixture was allowed to warm to rt and stirred for 20 h. The reaction was quenched with water (10 mL) 
and the product extracted with EtOAc (20 mL). The combined organic layers were washed with brine 
(20 mL), dried (MgSO4), concentrated, and subjected to column chromatography (hexanes) affording 
11 [17] (48 mg, 36%) as a colorless oil. This compound has been fully characterized previously [17]. 
NMR data for the sample prepared herein was consistent with the published data, with the exception 
that the quaternary aromatic carbon [As−C(sp2)] was significantly further downfield than previously 
reported (lit: δ = 132.5 [17], our sample: δ = 141.8). The identity of the sample prepared herein was 
also confirmed by high resolution mass spectrometry. 1H NMR (CDCl3, 500 MHz): δ 1.34-1.96 (m, 
10H), 7.21-7.44 (m, 5H); 13C NMR (CDCl3, 125 MHz): δ 22.7, 24.4, 29.0, 127.5, 128.7, 132.0, 141.8; 
MS (EI+): 222 (90%) [M]+, 152 (100%) [M−(CH2)5]
+; HRMS (ES+): calcd for C11H16As 223.0463, 
found 223.0459. 
 
Synthesis of 1-Phenyl-2,3-dihydro-1H-arsindole (12) 
A suspension of 1-bromo-2-(2-chloroethyl)benzene [27] (5.00 g, 22.78 mmol) and Mg (1.108 g, 45.56 
mmol) in THF (50 mL) was heated at reflux for 2 h. After cooling to rt, the resulting solution was add-
ed dropwise to a solution of (PhAsO)x (766 mg, 4.56 mmol) in THF (50 mL) at −78 °C and the mixture 
was allowed to warm to rt and stirred for 20 h. Water (50 mL) was slowly added and the mixture was 
extracted with Et2O (3×50 mL). The combined organic extracts were dried (MgSO4), concentrated and 
subjected to column chromatography (hexanes) giving 12 [20] (523 mg, 44%) as a colorless oil. This 
compound has not been fully characterized previously. FTIR: v 3384, 3046, 2360, 1435, 872, 765, 733, 
696 cm−1; 1H NMR (CDCl3, 300 MHz): δ 2.08-2.26 (m, 2H), 3.15-3.35 (m, 2H), 7.19-7.21 (m, 5H), 
7.20-7.36 (m, 3H), 7.65 (d, J = 6.6 Hz, 1H); 13C NMR (CDCl3, 75 MHz):  26.7, 36.4, 125.0, 126.5, 
127.7, 128.3, 128.6, 131.8, 131.9, 140.9, 142.7, 150.8; MS (EI+): 256 (77%) [M]+, 227 (40%), 179 





Synthesis of 1-Bromo-2-(2-chloroethyl)naphthalene (novel precursor to 13) 
A mixture of 2-(1-bromonaphthalen-2-yl)ethanol [28] (25.00 g, 99.55 mmol) and PCl5 (31.10 g, 149.33 
mmol) in CHCl3 (200 mL) was heated at reflux for 4 h. Upon cooling to rt, water (100 mL) was added 
dropwise and the mixture was diluted with CH2Cl2 (200 mL). The organic layer was separated and the 
aqueous layer was extracted with CH2Cl2 (2×150 mL). The combined organic layers were dried 
(MgSO4) then concentrated in vacuo and the residue subjected to silica gel chromatography. Elution 
with hexanes gave 1-bromo-2-(2-chloroethyl)naphthalene (25.50 g, 95%) as a pale yellow solid. mp: 
42−43 °C; FTIR: v 1321, 1259, 967, 817, 759, 706 cm−1; 1H NMR (CDCl3, 500 MHz): δ 3.44 (t, J = 
7.5 Hz, 2H), 3.82 (t, J = 7.5 Hz, 2H), 7.37 (d, J = 8.5 Hz, 1H), 7.50 (t, J = 8.0 Hz, 1H), 7.58 (t, J = 7.5 
Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.80 (d, J = 8.0 Hz, 1H), 8.31 (d, J = 8.5 Hz, 1H); 13C NMR (CDCl3, 
125 MHz): δ 40.7, 43.3, 124.5, 126.5, 127.5, 127.7, 127.9, 128.2, 128.6, 132.7, 133.8, 135.7; MS 
(EI+): 270 (99%) [M, 81Br/35Cl]+, 268 (100%) [M, 79Br/35Cl]+; HRMS (EI+): calcd for C12H10
79Br35Cl 
267.9654, found 267.9657. 
 
Synthesis of 1-Phenyl-2,3-dihydro-1H-benzo[g]arsindole (13) 
A suspension of Mg (1.45 g, 59.5 mmol) and 1-bromo-2-(2-chloroethyl)naphthalene (8.02 g, 29.76 
mmol) in THF (70 mL) was heated at reflux for 12 h. After cooling to rt, the dark grey/brown solution 
was added dropwise to a solution of (PhAsO)x (1.00 g, 5.95 mmol) in THF (70 mL) at −78 °C and the 
mixture was allowed to warm to rt and stirred for 20 h. Water (50 mL) was slowly added and the mix-
ture was extracted with Et2O (3×50 mL). The combined extracts were dried (MgSO4), concentrated 
and subjected to column chromatography (hexanes) giving 13 (746 mg, 41%) as a colorless oil. FTIR: 
v 3047, 2961, 2916, 2849, 1432, 1023, 810, 773, 734, 693 cm−1; 1H NMR (CDCl3, 500 MHz): δ 2.21-
2.27 (m, 1H), 2.32-2.38 (m, 1H), 3.48-3.51 (m, 2H), 7.14-7.19 (m, 5H), 7.41-7.49 (m, 3H), 7.81-7.86 
(m, 2H), 7.93-7.94 (m, 1H); 13C NMR (CDCl3, 125 MHz): 26.1, 37.9, 123.6, 125.2, 126.7, 127.9, 
128.27, 128.33, 128.7, 129.4, 132.1, 132.4, 135.3, 140.6, 140.7, 149.5; MS (ES+): 307 (30%) [M+H]+, 
323 (100%) [M+NH4]
+; HRMS (ES+): calcd for C18H16As 307.0468, found 307.0481. 
 
Synthesis of 1-Phenyl-1,2,3,4-tetrahydroarsinoline-1-oxide (14) 
A suspension of Mg (785 mg, 32.31 mmol) and 1-bromo-2-(3-bromopropyl)benzene [29] (4.49 g, 
16.15 mmol) in THF (10 mL) was stirred at rt for 12 h. The mixture was cooled to 0 °C and a solution 
of (PhAsO)x (679 mg, 4.04 mmol) in THF (10 mL) was added dropwise. The mixture was allowed to 
warm to rt and stirred for 20 h. The reaction was quenched with water (10 mL) and the product ex-
tracted with CH2Cl2 (20 mL). The combined organic layers were washed with brine (10 mL), dried 
(MgSO4), concentrated and subjected to column chromatography (petroleum ether) giving a mixture of 
1-phenyl-1,2,3,4-tetrahydroarsinoline (deoxo-14) and a Wurtz coupling-derived Grignard hydrolysis 
side product: 1,6-diphenylhexane (387 mg total). The mixture was taken up in acetone (10 mL) and 
H2O2 (30% aqueous, 167 mg total, 1.43 mmol H2O2) was added and the solution was stirred at rt for 12 
h. The solution was concentrated under reduced pressure and the residual solid was triturated with hex-
anes to provide 14 (340 mg, 26%) as a white foam. FTIR: v 3363, 2930, 1697, 1438, 1269, 1262, 1087, 
1066, 996, 874, 852, 802, 773, 743, 716 cm−1; 1H NMR (CDCl3, 500 MHz): δ 2.20-2.28 (m, 1H), 2.30-
2.40 (m, 1H), 2.52-2.60 (m, 1H), 2.70-2.78 (m, 1H), 2.88-2.96 (m, 1H), 3.04-3.12 (m, 1H), 7.24-7.72 
(m, 9H); 13C NMR (CDCl3, 125 MHz): δ 22.1, 30.9, 32.2, 128.1, 129.3, 129.5, 130.0, 130.7, 132.2, 
132.3, 132.5, 134.5, 145.2; MS (ES+): 287 (95%) [M+H]+, 572 (100%) [2M+H]+; HRMS (ES+): calcd 





Synthesis of (rac)-Trans-4,5-bis(bromomethyl)cyclohex-1-ene (novel precursor to 15) 
To a solution of (rac)-trans-4,5-bis(hydroxymethyl)cyclohex-1-ene [30] (13.25 g, 93.17 mmol) in 
CH2Cl2 (50 mL) at 0 °C was added sequentially NEt3 (32.3 mL, 232.91 mmol) and MsCl (15.9 mL, 
204.97 mmol) and the resulting suspension was allowed to warm to rt and stirred for 3 h. Water (50 
mL) was slowly added and the mixture was extracted with EtOAc (3×50 mL). The combined extracts 
were dried (MgSO4) and concentrated. The crude dimesylate was taken up in THF (100 mL) and LiBr 
(37.00 g, 426.05 mmol) was added. The resulting solution was then heated between 40−50 °C for 48 h. 
Water (50 mL) was added and the mixture was extracted with EtOAc (3×50 mL). The combined ex-
tracts were dried (MgSO4), concentrated and subjected to column chromatography (hexanes) giving 
(rac)-trans-4,5-bis(bromomethyl)cyclohex-1-ene (15.05 g, 60% over two steps) as a yellow oil. FTIR: 
v 3027, 2898, 1430, 1276, 1223, 1034, 978, 924, 850, 768, 668, 607 cm−1; 1H NMR (CDCl3, 300 
MHz): δ 1.98-2.25 (m, 6H), 3.45-3.53 (m, 2H), 3.60-3.67 (m, 2H), 5.64 (s, 2H); 13C NMR (CDCl3, 75 
MHz): δ 28.4, 36.2, 37.8, 125.0; MS (EI+): 270 (3%) [M, 81Br]+, 268 (6%) [M, 81Br/79Br]+, 266 (3%) 
[M, 79Br]+, 189 (45%) [M−Br, 81Br]+, 187 (49%) [M−Br, 79Br]+, 107 (100%). 
 
Synthesis of (rac)-Trans-2-phenyl-2,3,3a,4,7,7a-hexahydro-1H-isoarsindole (15) 
A suspension of Mg (0.363 g, 14.93 mmol) and (rac)-trans-4,5-bis(bromomethyl)cyclohex-1-ene 
(1.000 g, 3.73 mmol) in THF (4 mL) was stirred at rt for 1 h. The supernatant liquid was added drop-
wise to a solution of (PhAsO)x (0.125 g, 0.74 mmol) in THF (4 mL) at −78 °C and the mixture was al-
lowed to warm to rt and stirred for 20 h. Water (5 mL) was slowly added and the mixture was extracted 
with CH2Cl2 (3×10 mL). The combined extracts were dried (MgSO4), concentrated and subjected to 
column chromatography (hexanes) giving 15 (69 mg, 36%) as a colorless oil. FTIR: v 3858, 3019, 
2900, 1701, 1559, 1507, 1043, 774, 731, 694, 655 cm−1; 1H NMR (CDCl3, 500 MHz): δ 1.39-1.68 (m, 
4H), 1.79-1.94 (m, 2H), 2.22-2.45 (m, 3H), 2.50-2.57 (m, 1H), 5.61 (s, 2H),7.21-7.32 (m, 3H), 7.42-
7.48 (m, 2H); 13C NMR (CDCl3, 125 MHz): δ 33.9, 34.4, 35.2, 35.3, 43.3, 44.0, 126.6, 126.7, 127.4, 
128.4, 131.6, 143.5; MS (ES+): 261 (100%) [M+H]+; HRMS (ES+): calcd for C14H18As 261.0624, 
found 261.0634. 
 
Synthesis of (meso)-(2r,3aR,7aS)-2-Phenyl-2,3,3a,4,7,7a-hexahydro-1H-isoarsindole (16r) and (me-
so)-(2s,3aR,7aS)-2-Phenyl-2,3,3a,4,7,7a-hexahydro-1H-isoarsindole (16s) 
A suspension of Mg (0.308 g, 12.67 mmol) and (meso)-(4R,5S)-4,5-bis(bromomethyl)cyclohex-1-ene 
[31] (0.850 g, 3.17 mmol) in THF (3.4 mL) was stirred at rt for 1 h. The supernatant liquid was added 
dropwise to a solution of (PhAsO)x (0.107 g, 0.64 mmol) in THF (3.4 mL) at −78 °C and the mixture 
was allowed to warm to rt and stirred for 20 h. Water (5 mL) was slowly added and the mixture was 
extracted with CH2Cl2 (3×10 mL). The combined extracts were dried (MgSO4), concentrated and sub-
jected to column chromatography (hexanes) giving an inseparable mixture of meso-diastereomers 16s 
and 16r (67 mg, dr = 1:1, 41% combined yield) as a colorless oil. FTIR: v 3741, 2915, 1653, 1540, 
1038, 880, 732, 657 cm−1; 1H NMR (CDCl3, 500 MHz, as mixture): δ 1.65-2.40 (m, 20H), 5.48 (s, 2H), 
5.62 (s, 2H), 7.17-7.50 (m, 10H); 13C NMR (CDCl3, 125 MHz, as mixture): δ 27.9, 28.7, 31.1, 31.8, 
39.6, 39.7, 124.7, 125.2, 126.8, 127.4, 128.3, 128.4, 130.5, 131.7, 143.4, 145.6; MS (ES+): 261 (100%) 
[M+H]+; HRMS (ES+): calcd for C14H18As 261.0624, found 261.0616. 
 
Synthesis of 1-(4-Bromophenyl)arsolane (17) 
A suspension of Mg (470 mg, 19.33 mmol) and 1,4-dibromobutane (1.386 g, 6.42 mmol) in THF (12.8 
mL) was stirred at rt for 16 h. The supernatant liquid was added dropwise to a solution of (4-




to rt and stirred for 20 h. The reaction was quenched by the slow addition of saturated NH4Cl (10 mL), 
then water (20 mL) was added and the product was extracted with Et2O (2×20 mL). The combined or-
ganic extracts were washed with brine (20 mL), dried (Na2SO4), concentrated and subjected to column 
chromatography (petroleum ether) giving 17 (211.5 mg, 45%) as a colorless oil. FTIR: v 3331, 2917, 
1653, 1479, 1377, 1043, 1007, 799, 704 cm−1; 1H NMR (CDCl3, 300 MHz): δ 1.72-2.04 (m, 8H), 7.28 
(d, J = 8.2 Hz, 2H), 7.41 (d, J = 8.2 Hz, 2H); 13C NMR (CDCl3, 75 MHz): δ 27.5, 30.4, 121.6, 131.2, 
133.1, 142.2; MS (EI+): 288 (11%) [M, 81Br]+, 286 (11%) [M, 79Br]+, 232 (15%), 230 (19%), 71 
(100%); HRMS (EI+): calcd for C10H12As
79Br 285.9338, found 285.9349. 
 
Synthesis of 1-(4-Methoxyphenyl)arsolane (18) 
A suspension of Mg (245 mg, 10.10 mmol) and 1,4-dibromobutane (1.090 g, 5.05 mmol) in THF (5 
mL) was stirred at rt for 1 h. The resulting dark grey solution was added dropwise to a solution of (4-
OMePhAsO)x (200 mg, 1.01 mmol) in THF (9 mL) at −78 °C and the mixture was allowed to warm to 
rt and stirred for 20 h. Water (5 mL) was slowly added and the mixture was extracted with EtOAc 
(2×10 mL). The combined extracts were washed with brine (10 mL), dried (MgSO4), concentrated and 
subjected to column chromatography (hexanes) giving 18 (81.4 mg, 34%) as a colorless oil. FTIR: v 
3320, 2925, 2317, 1700, 1653, 1507, 1044, 668 cm−1; 1H NMR (CDCl3, 500 MHz): δ 1.73-1.95 (m, 
8H), 3.77 (s, 3H), 6.85 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.3 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 
27.7, 30.5, 55.2, 114.1, 132.9, 133.6, 159.4; MS (ES+): 239 (100%) [M+H]+; HRMS (ES+): calcd for 
C11H16AsO 239.0417, found 239.0424. 
 
Synthesis of 1-(Naphthalen-1-yl)arsolane (19) 
A suspension of Mg (223 mg, 9.17 mmol) and 1,4-dibromobutane (990 mg, 4.59 mmol) in THF (5 mL) 
was stirred at rt for 1 h. The resulting dark grey solution was added dropwise to a solution of (1-
naphthylAsO)x (200 mg, 0.92 mmol) in THF (9 mL) at −78 °C and the mixture was allowed to warm to 
rt and stirred for 20 h. Water (20 mL) was slowly added and the mixture was extracted with EtOAc 
(2×20 mL). The combined extracts were washed with brine (20 mL), dried (MgSO4), concentrated and 
subjected to column chromatography (hexanes) giving 19 (87.6 mg, 37%) as a colorless oil. FTIR: v 
3741, 2927, 1701, 1255, 1022, 947, 787, 770, 649 cm−1; 1H NMR (CDCl3, 500 MHz): δ 1.73-1.86 (m, 
4H), 1.97-2.09 (m, 4H), 7.36 (t, J = 7.6 Hz, 1H), 7.41-7.55 (m, 3H), 7.72 (d, J = 8.1 Hz, 1H), 7.80 (d, J 
= 7.6 Hz, 1H), 8.30 (d, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 26.3, 30.3, 125.2, 125.55, 
125.57, 126.7, 127.2, 127.9, 128.8, 133.9, 135.4, 140.5; MS (ES+): 259 (100%) [M+H]+; HRMS 
(ES+): calcd for C14H16As 259.0468, found 259.0468. 
 
Synthesis of 1-Phenylarsolane-1-oxide (20) 
Based on a literature procedure [15], to a solution of 10 (700 mg, 3.36 mmol) in acetone (10 mL) was 
added H2O2 (30% aqueous, 573 mg total, 5.05 mmol H2O2) and the solution was stirred at rt for 12 h. 
The solution was concentrated under reduced pressure and the residue subjected to column chromatog-
raphy (EtOAc to 20% NEt3/EtOAc) to afford 20
 [15] (678 mg, 90%) as a colorless oil. This compound 
has not been fully characterized previously. FTIR: v 3321, 2971, 2874, 1439, 1378, 1089, 1048, 879, 
863, 740, 692 cm−1; 1H NMR (CDCl3, 500 MHz): δ 1.97-2.05 (m, 2H), 2.13-2.28 (m, 6H), 7.50-7.60 
(m, 3H), 7.72-7.78 (m, 2H); 13C NMR (CDCl3, 125 MHz): δ 25.9, 29.2, 129.1, 129.5, 131.7, 134.8; 
MS (EI+): 224 (25%) [M]+, 169 (100%); HRMS (ES+): calcd for C10H14OAs 225.0261, found 
225.0255. 
 




To a solution of 11 (220 mg, 0.99 mmol) in acetone (5 mL) was added H2O2 (30% aqueous, 112 mg 
total, 0.99 mmol H2O2) and the solution was stirred at rt for 12 h. The solution was concentrated under 
reduced pressure and the residue was subjected to column chromatography (10:20:70 
MeOH:NEt3:EtOAc to 20:20:60 MeOH:NEt3:EtOAc) to give 21 (210 mg, 91%) as a yellow oil. FTIR: 
v 3335, 2922, 2853, 1434, 1089, 1021, 930, 887, 863, 809, 747, 740 cm−1; 1H NMR (CDCl3, 500 
MHz): δ 1.58-2.42 (m, 10H), 7.50-7.58 (m, 3H), 7.76-7.82 (m, 2H); 13C NMR (CDCl3, 125 MHz): δ 
23.3, 25.4, 29.5, 129.2, 129.9, 131.8, 133.6; MS (ES+): 239 (40%) [M+H]+, 477 (100%) [2M+H]+; 
HRMS (ES+): calcd for C11H16AsO, 239.0417 found 239.0420.  
 
Synthesis of 1-Phenyl-2,3-dihydro-1H-arsindole-1-oxide (22) 
To a solution of 12 (500 mg, 1.92 mmol) in acetone (10 mL) was added H2O2 (30% aqueous, 327 mg 
total, 2.88 mmol H2O2) and the solution was stirred at rt for 12 h. The solution was concentrated under 
reduced pressure and the residue subjected to column chromatography (EtOAc to 20% NEt3/EtOAc) to 
give 22 (468 mg, 89%) as a colorless oil. FTIR: v 3323, 3056, 1653, 1437, 1086, 866, 740, 691 cm−1; 
1H NMR (CDCl3, 500 MHz): δ 2.50-2.62 (m, 2H), 3.36-3.42 (m, 1H), 3.55-3.61 (m, 1H), 7.39-7.57 
(m, 5H), 7.65 (d, J = 7.5 Hz, 2H), 7.71 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): 27.5, 29.7, 
127.2, 128.5, 129.4, 129.8, 130.3, 132.1, 132.6, 132.7, 134.4, 146.3; MS (ES+): 273 (100%) [M+H]+; 
HRMS (ES+): calcd for C14H14OAs 273.0261, found 273.0251. 
 
Synthesis of 1-Phenyl-2,3-dihydro-1H-benzo[g]arsindole-1-oxide (23) 
To a solution of 13 (400 mg, 1.31 mmol) in acetone (10 mL) was added H2O2 (30% aqueous, 222 mg 
total, 1.96 mmol H2O2) and the solution was stirred at rt for 12 h. The solution was concentrated under 
reduced pressure and the residual solid was triturated with cold CH2Cl2 providing 23 (394 mg, 94%) as 
a white solid. mp: 106−107 °C; FTIR: v 3104, 2830, 845, 811, 744, 692 cm−1; 1H NMR (CDCl3, 500 
MHz): δ 2.62-2.68 (m, 1H), 2.76-2.82 (m, 1H), 3.53-3.59 (m, 1H), 3.71-3.77 (m, 1H), 7.46-7.51 (m, 
6H), 7.70 (d, J = 7.5 Hz, 2H), 7.90 (d, J = 7.5 Hz, 1H), 7.98 (d, J = 7.5 Hz, 1H), 8.03 (d, J = 8.5 Hz, 
1H); 13C NMR (CDCl3, 125 MHz): δ 27.1, 30.2, 124.3, 126.0, 126.6, 128.1, 128.3, 128.7, 129.3, 129.9, 
132.0, 132.1, 133.0, 133.5, 134.5, 146.4; MS (ES+): 323 (100%) [M+H]+; HRMS (ES+): calcd for 
C18H16AsO 323.0417, found 323.0425. 
 
Synthesis of 1-(4-Methoxyphenyl)arsolane-1-oxide (24) 
To a solution of 18 (39.8 mg, 0.17 mmol) in acetone (1.2 mL) was added H2O2 (30% aqueous, 19.2 mg 
total, 0.17 mmol H2O2) and the solution was stirred at rt for 30 min. The solution was concentrated un-
der reduced pressure and the residue subjected to column chromatography (CH2Cl2 to 10% 
MeOH/CH2Cl2) to give 24 (33 mg, 79%) as a colorless oil. FTIR: v 3353, 2941, 1507, 1090, 1019, 
884, 868, 821, 794, 752, 608 cm−1; 1H NMR (CDCl3, 500 MHz): δ 1.96-2.25 (m, 8H), 3.86 (s, 3H), 
7.04 (d, J = 8.5 Hz, 2H), 7.65 (d, J = 8.5 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 25.9, 29.3, 55.4, 
114.9, 125.3, 131.2, 162.4; MS (ES+): 255 (100%) [M+H]+; HRMS (ES+): calcd for C11H16AsO2 
255.0366, found 255.0360. 
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